XL-protein Competitors and Similar CompaniesClear all
XL-protein's competitors and similar companies include Tiburio Therapeutics, Faraday Pharmaceuticals and Cyclogenix.
 XL-protein XL-protein is a company that develops and commercializes its proprietary PASylation technology to extend the plasma half-life of biopharmaceuticals. |  Faraday Pharmaceuticals Faraday Pharmaceuticals is a company specializing in the use of elemental reducing agents to support the quality of life after acute, critical illness. | |||
Founding Date | Founding Date 2009 | Founding Date 2018 | Founding Date 2014 | Founding Date 2008 |
Type | Type Private | Type Private | Type Private | Type Private |
Tags | ||||
Locations | Locations Freising, DE HQ | Locations Cambridge, US HQ | Locations Seattle, US HQ | Locations Stevenage, GB HQ |
Employees | Employees 5 | Employees 722% decrease | Employees 274% increase | Employees 3 |
Funding | ||||
Latest funding round | Latest funding round N/A | Latest funding round $ 31m (over 7 years ago) | Latest funding round $ 25m (almost 7 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised N/A | Total funding raised $ 31m | Total funding raised $ 88m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Tiburio Therapeutics
HQ
Cambridge, US
Employees
7↓ 22% decrease
Tiburio Therapeutics is a biopharmaceutical company.
View companyFaraday Pharmaceuticals
HQ
Seattle, US
Employees
27↑ 4% increase
Faraday Pharmaceuticals is a company specializing in the use of elemental reducing agents to support the quality of life after acute, critical illness.
View company
Cyclogenix
HQ
Stevenage, GB
Employees
3
Cyclogenix is a biotech company focused on antibody and peptide discovery.
View company